JPH07500593A - 非イオン性ポリアクリルアミド誘導体を含有した低pH水性化粧品ゲル - Google Patents
非イオン性ポリアクリルアミド誘導体を含有した低pH水性化粧品ゲルInfo
- Publication number
- JPH07500593A JPH07500593A JP5507770A JP50777093A JPH07500593A JP H07500593 A JPH07500593 A JP H07500593A JP 5507770 A JP5507770 A JP 5507770A JP 50777093 A JP50777093 A JP 50777093A JP H07500593 A JPH07500593 A JP H07500593A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- acid
- drugs
- group
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Abstract
Description
Claims (10)
- 1.1,000,000〜30,000,000の分子量を有する非イオン性ポ リアクリルアミド0.05〜20%を含む水性ゲル形態のスキンケア組成物であ って、 4以下のpHを有する組成物。
- 2.ポリアクリルアミドが、非置換であるか又は炭素原子1〜5を有する少くと も1つのアルキル基で置換されたアクリルアミド及びメタクリルアミドから選択 されるモノマーを含み、好ましくはポリアクリルアミドが,アクリルアミド、メ タクリルアミド、N−メチルアクリルアミド、N−メチルメタクリルアミド、N ,N−ジメチルメタクリルアミド、N−イソプロピルアクリルアミド、N−イソ プロピルメタクリルアミド及びN,N−ジメチルアクリルアミドからなる群より 選択されるモノマーを含む、請求項1に記載の組成物。
- 3.組成物が3,5以下のpHを有する、請求項2に記載の組成物。
- 4.組成物が保湿剤を更に含み、好ましくはその保温剤が、ポリヒドロキシアル コール類、グリセリン、ヘキサントリオール、プロピレングリコール、ヘキシレ ングリコール、ポリエチレングリコール、2−ピロリドン−5−カルボン酸、D −バンテノール、ヒアルロン酸、ラクダミドモノエタノールアミン、アセトアミ ドモノエタノールアミン及びそれらの混合物からなる群より選択される、請求項 3に記載の組成物。
- 5.組成物が0.1〜20%の医薬活性剤を更に含む、請求項4に記載の組成物 。
- 6.医薬活性剤が、抗アクネ薬、非ステロイド系抗炎症薬、ステロイド系抗炎症 薬、無日光日焼け点化剤、日焼け止め剤、創傷治癒剤、皮膚漂白又は淡点化剤、 抗ヒスタミン薬、鎮咳薬、止痛薬、抗コリン作動薬、制吐及び抗悪心薬、食欲抑 制薬、中枢刺激薬、抗不整脈薬、β−アドレナリン遮断薬、強心葉、降圧薬、利 尿薬、血管拡張薬、血管収縮薬、抗演潰瘍薬、麻酔薬、抗うつ薬、トランキライ ザー、鎮静薬、抗精神病薬、抗菌薬、抗新生物薬、抗マラリア薬、筋肉弛緩薬、 鎮痙薬、止潟薬、骨活性薬とそれらの混合物からなる群より選択される、請求項 5に記載の組成物。
- 7.組成物が皮膚軟化剤を更に含み、好ましくはその皮膚軟化剤が、ポリアルキ ルシロキサン、ポリアルキルアリールシロキサン及びポリエーテルシロキサンコ ポリマーからなる群より選択される非揮発性シリコーン油である、請求項6に記 載の組成物。
- 8.医薬活性剤が、サリチル酸、イオウ、レゾルシノール、N−アセチルシステ イン、オクトピロックス、レチノイン酸及びその誘導体、過酸化ベンゾイル、エ リトロマイシン、テトラサイクリン、アゼライン酸及びその誘導体、フェノキシ エタノール及びフエノキシプロパノール、酢酸エチル、クリンダマイシン、メク ロサイクリン、フラビノイド類、乳酸、グリコール酸、ピルビン酸、フマル酸、 尿素、硫酸シムノール及びその誘導体、デオキシコール酸塩、コール酸塩とそれ らの混合物からなる群より選択される抗アクネ活性剤である、請求項7に記載の 組成物。
- 9.医薬活性剤が、サリチル酸、イオウ、レゾルシノール、オケトピロックス、 レチノイン酸及びその誘導体、過酸化ベンゾイル、エリトロマイシン、テトラサ イクリンとそれらの混合物からなる群より選択される抗アクネ活性剤である、請 求項8に記載の組成物。
- 10.薬物活性剤が、ジヒドロキシアセトン、インドール誘導体及びそれらの混 合物からなる群より選沢される無日光日焼け点化剤であり、組成物が日焼け止め 活性剤を更に含む、請求項9に記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77842391A | 1991-10-16 | 1991-10-16 | |
US778,423 | 1991-10-16 | ||
PCT/US1992/008743 WO1993007856A1 (en) | 1991-10-16 | 1992-10-13 | LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07500593A true JPH07500593A (ja) | 1995-01-19 |
JP3555762B2 JP3555762B2 (ja) | 2004-08-18 |
Family
ID=25113303
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50777093A Expired - Lifetime JP3555762B2 (ja) | 1991-10-16 | 1992-10-13 | 非イオン性ポリアクリルアミド誘導体を含有した低pH水性化粧品ゲル |
Country Status (25)
Country | Link |
---|---|
US (1) | US5707635A (ja) |
EP (1) | EP0608353B1 (ja) |
JP (1) | JP3555762B2 (ja) |
KR (1) | KR100244554B1 (ja) |
CN (1) | CN1050283C (ja) |
AT (1) | ATE133560T1 (ja) |
AU (1) | AU675210B2 (ja) |
BR (1) | BR9206630A (ja) |
CA (1) | CA2119636C (ja) |
CZ (1) | CZ90494A3 (ja) |
DE (1) | DE69208098T2 (ja) |
DK (1) | DK0608353T3 (ja) |
ES (1) | ES2083197T3 (ja) |
FI (1) | FI941769A0 (ja) |
GR (1) | GR3018853T3 (ja) |
HK (1) | HK1007504A1 (ja) |
HU (1) | HUT66957A (ja) |
MA (1) | MA22677A1 (ja) |
MX (1) | MX9205905A (ja) |
NO (1) | NO941318L (ja) |
NZ (1) | NZ244744A (ja) |
PT (1) | PT100962B (ja) |
SK (1) | SK43994A3 (ja) |
TR (1) | TR26721A (ja) |
WO (1) | WO1993007856A1 (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031549A (ja) * | 1999-07-14 | 2001-02-06 | Pola Chem Ind Inc | 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料 |
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
JP2011037904A (ja) * | 2001-12-21 | 2011-02-24 | Galderma Research & Development | 少なくとも一つのレチノイド及び過酸化ベンゾイルを含むゲル組成物 |
JP2013075848A (ja) * | 2011-09-30 | 2013-04-25 | Nippon Menaade Keshohin Kk | 抗炎症剤 |
US10925814B2 (en) | 2006-12-21 | 2021-02-23 | Galderma Research & Development | Cream gels comprising at least one retinoid and benzoyl peroxide |
Families Citing this family (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993007902A1 (en) * | 1991-10-16 | 1993-04-29 | Richardson-Vicks, Inc. | Enhanced skin penetration system for improved topical delivery of drugs |
EG20380A (en) | 1991-10-16 | 1999-02-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
CA2134979A1 (en) * | 1992-05-05 | 1993-11-11 | Spencer Guang Lin | Acne treating composition |
BR9306816A (pt) * | 1992-07-28 | 1998-12-08 | Procter & Gamble | Composição farmaceutica para uso tópico contendo um polímero catiônico reticulado e um eter alcoxilado |
US5989536A (en) * | 1993-07-03 | 1999-11-23 | The Procter & Gamble Company | Personal cleansing compositions containing alkoxylated ether and cationic ammonium salt for deposition of active agent upon the skin |
US6001379A (en) * | 1993-09-15 | 1999-12-14 | L'oreal | Stable acidic oil-in- water type emulsions and compositions containing them |
FR2709982B1 (fr) * | 1993-09-15 | 1995-12-08 | Oreal | Emulsions acides stables de type huile-dans-eau et compositions les contenant. |
ZA947912B (en) * | 1993-10-12 | 1995-05-24 | Broadbent J W Nominees Pty Ltd | Treatment of medical disorders associated with free radical formation |
FR2718640B1 (fr) * | 1994-04-18 | 1996-05-15 | Oreal | Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations. |
US5422112A (en) * | 1994-06-09 | 1995-06-06 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Thickened cosmetic compositions |
DE19538555A1 (de) * | 1995-10-17 | 1997-04-24 | Beiersdorf Ag | Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen |
NL1003992C2 (nl) * | 1996-09-10 | 1998-03-11 | Stein Gerrit Cornelis Johan | Therapeutische gel met ongeneutraliseerde alfa-hydroxyzuren als werkzame componenten. |
FR2759286B1 (fr) * | 1997-02-10 | 2004-04-02 | Oreal | Utilisation de polymeres presentant une temperature critique du type lcst ou du type ucst dans et pour la fabrication de formulations cosmetiques ou dermatologiques compositions les contenant |
US20030150575A1 (en) * | 1998-06-04 | 2003-08-14 | Snf Sa | Paper and paperboard production process and corresponding novel retention and drainage aids, and papers and paperboards thus obtained |
US6183766B1 (en) * | 1999-02-12 | 2001-02-06 | The Procter & Gamble Company | Skin sanitizing compositions |
US6200964B1 (en) | 1999-05-28 | 2001-03-13 | Neutrogena Corporation | Silicone gel containing salicylic acid |
US6342206B1 (en) * | 1999-12-27 | 2002-01-29 | Sridhar Gopalkrishnan | Aqueous gels comprising ethoxylated polyhydric alcohols |
US6335001B1 (en) * | 1999-12-27 | 2002-01-01 | Basf Corporation | Carrier blends for dentifrices comprising ethoxlated polyhydric alcohols |
US6632845B1 (en) * | 2000-06-26 | 2003-10-14 | Diane M. Gassiraro | Method for improving muscle control and muscle tone and improving sensory integration |
FR2810883B1 (fr) | 2000-06-28 | 2006-07-28 | Seppic Sa | Nouveaux latex inverses autoinversibles sur des esters d'acides gras, compositions cosmetiques, dermocosmetiques, dermopharmaceutiques ou pharmaceutiques en comportant |
US6387383B1 (en) * | 2000-08-03 | 2002-05-14 | Dow Pharmaceutical Sciences | Topical low-viscosity gel composition |
US6685917B2 (en) * | 2000-11-22 | 2004-02-03 | Rxkinetix, Inc. | Treatment of mucositis |
US6429231B1 (en) * | 2001-09-24 | 2002-08-06 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
US20030064084A1 (en) * | 2001-09-24 | 2003-04-03 | Bradley Pharmaceuticals, Inc. | Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use |
FR2829938B1 (fr) * | 2001-09-24 | 2004-10-29 | Fabre Pierre Dermo Cosmetique | Composition dermocosmetologique a visee anti-inflammatoire, en particulier pour le traitement de l'acne et de la dermite seborrheique |
US7074832B2 (en) | 2001-09-24 | 2006-07-11 | Bradley Pharmaceuticals, Inc. | Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use |
FR2829937B1 (fr) * | 2001-09-24 | 2004-11-05 | Fabre Pierre Dermo Cosmetique | Composition dermocosmetologique a visee anti-inflammatoire, en particulier pour le traitement de l'acne et de la dermite seborrheique |
US20030138466A1 (en) * | 2001-11-28 | 2003-07-24 | Bradley Pharmaceuticals, Inc. | Antioxidant dermatological composition |
US6986896B2 (en) * | 2002-03-20 | 2006-01-17 | Bradley Pharmaceuticals, Inc. | Method of treating fungal conditions of the skin |
US6743417B2 (en) | 2002-04-22 | 2004-06-01 | Bradley Pharmaceuticals, Inc. | Method of treating onychomycosis with urea and an antioxidant |
US20030206893A1 (en) * | 2002-05-06 | 2003-11-06 | Sohail Malik | Cell proliferating agents |
US20040171561A1 (en) * | 2002-09-03 | 2004-09-02 | Popp Karl F. | Topical formulations for treatment of rosacea |
US20040043946A1 (en) * | 2002-09-03 | 2004-03-04 | Popp Karl F. | Topical formulations for treatment of skin disorders |
US20040167223A1 (en) * | 2002-09-03 | 2004-08-26 | Popp Karl F. | Topical antibacterial formulations |
US20040156870A1 (en) * | 2003-02-11 | 2004-08-12 | Bradley Pharmaceuticals, Inc. | Use of urea as a method for improving the effectiveness of topical anti-inflammatory drugs |
US20050118261A1 (en) * | 2003-06-12 | 2005-06-02 | Oien Hal J. | Compositions and methods of administering doxepin to mucosal tissue |
FR2856691B1 (fr) | 2003-06-26 | 2005-08-26 | Seppic Sa | Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant |
FR2861397B1 (fr) | 2003-10-22 | 2006-01-20 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau latex inverse concentre, procede pour sa preparation et utilisation dans l'industrie |
US9572754B2 (en) | 2004-03-04 | 2017-02-21 | L'oreal | Transparent self-tanning gels containing a water-soluble/dispersible acrylamido-2-methylpropanesulfonic acid polymer |
FR2867070B1 (fr) * | 2004-03-04 | 2009-07-10 | Oreal | Gel autobronzant transparent contenant un polymere d'acide acrylamido 2-methyl propane sulfonique hydrosoluble ou hydrodispersible |
US8158138B1 (en) | 2004-05-20 | 2012-04-17 | Fougera Pharmaceuticals, Inc. | Urea compositions and their methods of manufacture |
FR2879607B1 (fr) | 2004-12-16 | 2007-03-30 | Seppic Sa | Nouveaux latex inverse concentre, procede pour sa preparation, et utilisation dans l'industrie |
AR054805A1 (es) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | Composiciones topicas para el tratamiento de la piel |
EP1965787B1 (en) * | 2005-11-30 | 2013-04-10 | Endo Pharmaceuticals Inc. | Treatment of xerostomia with a sulfur-containing antioxidant |
US9107844B2 (en) * | 2006-02-03 | 2015-08-18 | Stiefel Laboratories Inc. | Topical skin treating compositions |
WO2008007224A2 (en) | 2006-03-31 | 2008-01-17 | Stiefel Research Australia Pty Ltd | Foamable suspension gel |
CN100446773C (zh) * | 2006-04-29 | 2008-12-31 | 王菊荣 | 复方痤疮微乳膏及制备方法 |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
CN100463930C (zh) * | 2006-12-21 | 2009-02-25 | 天津大学 | 可再分散pH敏感型阳离子聚合物水凝胶亚微米粒及制备方法 |
FR2950060B1 (fr) | 2009-09-11 | 2011-10-28 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau polymere en poudre, procede pour sa preparation et utilisation comme epaississant |
FR2959746B1 (fr) | 2010-05-06 | 2012-06-15 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau latex inverse auto-inversible, son utilisation comme agent epaississant dans une composition cosmetique |
FR2969493B1 (fr) * | 2010-12-23 | 2013-07-05 | Galderma Res & Dev | Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant du bpo |
FR2969491B1 (fr) * | 2010-12-23 | 2013-07-12 | Galderma Res & Dev | Mousses dermatologiques obtenues a partir d'un gel ou d'une suspension contenant une combinaison d'adapalene et de bpo |
FR2986004B1 (fr) | 2012-01-25 | 2014-03-14 | Seppic Sa | Nouveau polymere epaississant reduisant le caractere collant des formules cosmetiques a base de glycerine |
FR2987361B1 (fr) | 2012-02-29 | 2014-07-18 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau polymere d'acrylate de silicone et de methacrylate de trifluoro-ethyle, preparation et utilisation en cosmetique |
FR2987839B1 (fr) | 2012-03-08 | 2014-05-09 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau polymere d'acrylate de silicone et d'acide acrylique epaississant et reduisant le caractere collant des formules cosmetiques a base de glycerine |
FR2992323B1 (fr) | 2012-06-25 | 2015-07-03 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Nouveau latex inverse auto-inversible exempt de tensioactif, son utilisation comme agent epaississant dans une composition cosmetique |
CN104780902A (zh) * | 2012-10-29 | 2015-07-15 | 日本乐敦制药株式会社 | 外用组合物 |
US9238774B2 (en) | 2012-11-02 | 2016-01-19 | Empire Technology Development Llc | Soil fixation, dust suppression and water retention |
US9174871B2 (en) | 2012-11-02 | 2015-11-03 | Empire Technology Development Llc | Cement slurries having pyranose polymers |
CN102885764A (zh) * | 2012-11-02 | 2013-01-23 | 江苏吉贝尔药业有限公司 | 一种新的乙酰半胱氨酸凝胶的制备方法 |
WO2014088555A1 (en) | 2012-12-04 | 2014-06-12 | Empire Technology Development Llc | High performance acrylamide adhesives |
US10912956B2 (en) | 2016-03-23 | 2021-02-09 | Mary Kay Inc. | Cosmetic compositions and uses thereof |
CN114788791A (zh) | 2017-06-23 | 2022-07-26 | 宝洁公司 | 用于改善皮肤外观的组合物和方法 |
US20210102059A1 (en) * | 2018-03-30 | 2021-04-08 | Sekisui Kasei Co., Ltd. | Hydrogel |
CN108467464A (zh) * | 2018-04-02 | 2018-08-31 | 常熟理工学院 | 含壬二酸可见光固化水凝胶及其制备方法 |
WO2020010036A1 (en) | 2018-07-03 | 2020-01-09 | The Procter & Gamble Company | Method of treating a skin condition |
CN108553411B (zh) * | 2018-07-25 | 2020-05-12 | 成都卓阳生物科技有限公司 | 壬二酸凝胶剂及其制备方法和应用 |
US11154472B2 (en) * | 2019-04-29 | 2021-10-26 | L'oreal | Compositions comprising solvent, a monoalcohol, glycerin, and thickener |
US11583488B2 (en) | 2020-06-01 | 2023-02-21 | The Procter & Gamble Company | Method of improving penetration of a vitamin B3 compound into skin |
US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS582341A (ja) * | 1981-06-15 | 1983-01-07 | アルコン・ラボラトリ−ズ・インコ−ポレ−テツド | カルボキシビニル重合物−尿素ゲル組成物 |
JPS6113957A (ja) * | 1984-06-27 | 1986-01-22 | セイムア エフ.トレイガー | 眼科領域における手術・治療用注入可能粘弾性ゲル |
JPH02112A (ja) * | 1987-09-18 | 1990-01-05 | Ethicon Inc | 生長因子を含有するゲル配合物 |
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3920810A (en) | 1974-04-23 | 1975-11-18 | Burton Parsons And Company Inc | Polyacrylamide containing ophthalmic solutions |
US4039501A (en) * | 1975-05-30 | 1977-08-02 | National Patent Development Corporation | Plasticized hydrophilic polymers |
US4355028A (en) * | 1978-04-04 | 1982-10-19 | Westwood Pharmaceuticals, Inc. | Composition for treating acne vulgaris |
US4318907A (en) * | 1978-04-04 | 1982-03-09 | Westwood Pharmaceuticals, Inc. | Method for treating acne vulgaris and compositions useful for that purpose |
US4954487A (en) * | 1979-01-08 | 1990-09-04 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions |
JPS596287B2 (ja) * | 1980-11-28 | 1984-02-10 | 日東電工株式会社 | 医薬製剤 |
US4478853A (en) * | 1982-05-17 | 1984-10-23 | S. C. Johnson & Son, Inc. | Skin conditioning composition |
US4863725A (en) | 1982-10-27 | 1989-09-05 | Deckner George E | Novel clear oil-free moisturizer composition |
GB8401206D0 (en) | 1984-01-17 | 1984-02-22 | Allied Colloids Ltd | Polymers and aqueous solutions |
GB8414950D0 (en) | 1984-06-12 | 1984-07-18 | Allied Colloids Ltd | Cationic polyelectrolytes |
GB8416453D0 (en) * | 1984-06-28 | 1984-08-01 | Allied Colloids Ltd | Aqueous polymer dispersions |
US5017367A (en) * | 1984-10-01 | 1991-05-21 | Stojkoski Radmila G | Skin treatment preparation |
US4806345C1 (en) * | 1985-11-21 | 2001-02-06 | Johnson & Son Inc C | Cross-linked cationic polymers for use in personal care products |
GB8531118D0 (en) * | 1985-12-18 | 1986-01-29 | Allied Colloids Ltd | Copolymers |
US4827019A (en) * | 1985-12-24 | 1989-05-02 | Eastman Kodak Company | Sterically hindered aromatic carboxylic esters |
US4731242A (en) * | 1986-03-21 | 1988-03-15 | Victor Palinczar | Waterproof sunscreen compositions |
US4704436A (en) * | 1986-05-02 | 1987-11-03 | Barabas Eugene S | Water soluble complex of a poly(vinylpyrrolidone) copolymer and α-methyl-(2-methylpropyl)benzene acetic acid |
US4837019A (en) | 1986-08-11 | 1989-06-06 | Charles Of The Ritz Group Ltd. | Skin treatment composition and method for treating burned skin |
GB8622797D0 (en) * | 1986-09-22 | 1986-10-29 | Allied Colloids Ltd | Polymeric particles |
CA1329283C (en) * | 1986-10-01 | 1994-05-03 | David Farrar | Water soluble polymeric compositions |
US4885161A (en) * | 1987-03-11 | 1989-12-05 | Medi-Tech International Corporation | Wound dressings in gelled paste form |
US4929577A (en) * | 1987-03-11 | 1990-05-29 | Medi-Tech International Corporation | Transparent wound dressings in sheet form |
CA1305069C (en) | 1987-03-11 | 1992-07-14 | John Cornell | Wound dressings in sheet or gelled paste form |
JPH07116035B2 (ja) * | 1987-12-08 | 1995-12-13 | 塩野義製薬株式会社 | 被膜形成性抗真菌剤組成物 |
US4963348A (en) | 1987-12-11 | 1990-10-16 | The Procter & Gamble Company | Styling agents and compositions containing the same |
JPH0749050B2 (ja) * | 1988-01-18 | 1995-05-31 | 久光製薬株式会社 | 含水ゲル組成物 |
GB8909095D0 (en) * | 1989-04-21 | 1989-06-07 | Allied Colloids Ltd | Thickened aqueous compositions |
US5009969A (en) * | 1989-05-26 | 1991-04-23 | Hi-Tek Polymers, Inc. | Dual action sunscreen composition |
GB2236760A (en) * | 1989-10-11 | 1991-04-17 | Inverness Corp | Shaving gel |
US5043359A (en) * | 1990-03-05 | 1991-08-27 | Dow Corning Corporation | Skin conditioning compositions containing glyceroxyfunctional silanes and siloxanes |
US5221530A (en) * | 1991-06-24 | 1993-06-22 | Helene Curtis, Inc. | Mild conditioning shampoo with a high foam level containing an anionic surfactant-cationic acrylate/acrylamide copolymer conditioning agent |
EG20380A (en) * | 1991-10-16 | 1999-02-28 | Richardson Vicks Inc | Enhanced skin penetration system for improved topical delivery of drugs |
WO1993007902A1 (en) * | 1991-10-16 | 1993-04-29 | Richardson-Vicks, Inc. | Enhanced skin penetration system for improved topical delivery of drugs |
US5232688A (en) * | 1992-06-17 | 1993-08-03 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Self-tanner cosmetic compositions |
US5425938A (en) * | 1994-01-28 | 1995-06-20 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Polyamino salts of alpha-hydroxyacids, alpha-ketoacids and related compounds |
-
1992
- 1992-10-13 HU HU9401105A patent/HUT66957A/hu unknown
- 1992-10-13 EP EP92922437A patent/EP0608353B1/en not_active Expired - Lifetime
- 1992-10-13 DK DK92922437.6T patent/DK0608353T3/da active
- 1992-10-13 DE DE69208098T patent/DE69208098T2/de not_active Expired - Lifetime
- 1992-10-13 CA CA002119636A patent/CA2119636C/en not_active Expired - Fee Related
- 1992-10-13 JP JP50777093A patent/JP3555762B2/ja not_active Expired - Lifetime
- 1992-10-13 ES ES92922437T patent/ES2083197T3/es not_active Expired - Lifetime
- 1992-10-13 BR BR9206630A patent/BR9206630A/pt not_active Application Discontinuation
- 1992-10-13 MA MA22963A patent/MA22677A1/fr unknown
- 1992-10-13 SK SK439-94A patent/SK43994A3/sk unknown
- 1992-10-13 KR KR1019940701238A patent/KR100244554B1/ko not_active IP Right Cessation
- 1992-10-13 AU AU28000/92A patent/AU675210B2/en not_active Ceased
- 1992-10-13 AT AT92922437T patent/ATE133560T1/de not_active IP Right Cessation
- 1992-10-13 WO PCT/US1992/008743 patent/WO1993007856A1/en not_active Application Discontinuation
- 1992-10-13 CZ CS94904A patent/CZ90494A3/cs unknown
- 1992-10-15 MX MX9205905A patent/MX9205905A/es unknown
- 1992-10-15 PT PT100962A patent/PT100962B/pt not_active IP Right Cessation
- 1992-10-15 NZ NZ244744A patent/NZ244744A/en unknown
- 1992-10-16 TR TR92/1008A patent/TR26721A/xx unknown
- 1992-10-16 CN CN92113394A patent/CN1050283C/zh not_active Expired - Lifetime
-
1994
- 1994-04-13 NO NO941318A patent/NO941318L/no unknown
- 1994-04-15 FI FI941769A patent/FI941769A0/fi not_active Application Discontinuation
- 1994-05-25 US US08/249,093 patent/US5707635A/en not_active Expired - Lifetime
-
1996
- 1996-02-01 GR GR960400068T patent/GR3018853T3/el unknown
-
1998
- 1998-06-25 HK HK98106795A patent/HK1007504A1/xx not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS582341A (ja) * | 1981-06-15 | 1983-01-07 | アルコン・ラボラトリ−ズ・インコ−ポレ−テツド | カルボキシビニル重合物−尿素ゲル組成物 |
JPS6113957A (ja) * | 1984-06-27 | 1986-01-22 | セイムア エフ.トレイガー | 眼科領域における手術・治療用注入可能粘弾性ゲル |
JPH02112A (ja) * | 1987-09-18 | 1990-01-05 | Ethicon Inc | 生長因子を含有するゲル配合物 |
JPH02258718A (ja) * | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001031549A (ja) * | 1999-07-14 | 2001-02-06 | Pola Chem Ind Inc | 真皮コラーゲン線維束再構築剤及びそれを含有する化粧料 |
US7820186B2 (en) | 2001-12-21 | 2010-10-26 | Galderma Research & Development | Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
JP2011037904A (ja) * | 2001-12-21 | 2011-02-24 | Galderma Research & Development | 少なくとも一つのレチノイド及び過酸化ベンゾイルを含むゲル組成物 |
US7964202B2 (en) | 2001-12-21 | 2011-06-21 | Galderma Research & Development, S.N.C. | Method for treatment of common acne |
US8105618B2 (en) | 2001-12-21 | 2012-01-31 | Galderma Research & Development | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
US8241649B2 (en) | 2001-12-21 | 2012-08-14 | Galderma Research & Development | Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide |
US8936800B2 (en) | 2001-12-21 | 2015-01-20 | Galderma Research & Development | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
US9814690B2 (en) | 2001-12-21 | 2017-11-14 | Galderma Research & Development | Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt |
US10925814B2 (en) | 2006-12-21 | 2021-02-23 | Galderma Research & Development | Cream gels comprising at least one retinoid and benzoyl peroxide |
JP2013075848A (ja) * | 2011-09-30 | 2013-04-25 | Nippon Menaade Keshohin Kk | 抗炎症剤 |
Also Published As
Publication number | Publication date |
---|---|
MX9205905A (es) | 1993-06-01 |
PT100962B (pt) | 1999-07-30 |
MA22677A1 (fr) | 1993-07-01 |
KR100244554B1 (ko) | 2000-04-01 |
CN1072843A (zh) | 1993-06-09 |
BR9206630A (pt) | 1995-04-25 |
AU675210B2 (en) | 1997-01-30 |
AU2800092A (en) | 1993-05-21 |
SK43994A3 (en) | 1995-01-12 |
CA2119636C (en) | 1998-06-23 |
DE69208098D1 (de) | 1996-03-14 |
ATE133560T1 (de) | 1996-02-15 |
DE69208098T2 (de) | 1996-08-08 |
HUT66957A (en) | 1995-01-30 |
GR3018853T3 (en) | 1996-05-31 |
FI941769A (fi) | 1994-04-15 |
HU9401105D0 (en) | 1994-07-28 |
TR26721A (tr) | 1995-05-15 |
JP3555762B2 (ja) | 2004-08-18 |
CN1050283C (zh) | 2000-03-15 |
EP0608353A1 (en) | 1994-08-03 |
CA2119636A1 (en) | 1993-04-29 |
NO941318L (no) | 1994-06-15 |
NZ244744A (en) | 1995-07-26 |
NO941318D0 (no) | 1994-04-13 |
ES2083197T3 (es) | 1996-04-01 |
CZ90494A3 (en) | 1994-07-13 |
WO1993007856A1 (en) | 1993-04-29 |
EP0608353B1 (en) | 1996-01-31 |
FI941769A0 (fi) | 1994-04-15 |
PT100962A (pt) | 1993-11-30 |
US5707635A (en) | 1998-01-13 |
HK1007504A1 (en) | 1999-04-16 |
DK0608353T3 (da) | 1996-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07500593A (ja) | 非イオン性ポリアクリルアミド誘導体を含有した低pH水性化粧品ゲル | |
US5420118A (en) | Gel type cosmetic compositions | |
AU2005215214B2 (en) | Skincare compositions | |
KR0159271B1 (ko) | 하이드록시알킬화 사이클로덱스트린으로 포접한 포접물을 포함하는 화장품 및 분말 화장품 | |
US9827194B2 (en) | Surfactant-free oil-in-water type emulsion, process for preparation thereof and its uses | |
EP0735861A1 (en) | Tissue moisturizing and antimicrobial compositions | |
JP2000119131A (ja) | 親水性の増粘化合物と増粘コポリマ―を含有するエマルション及び該エマルションを含有する組成物及びその使用 | |
JPH07506367A (ja) | アクネ治療組成物 | |
CN107108905A (zh) | 水溶性超分子复合物 | |
US20030202951A1 (en) | Method for reducing the appearance of dark circles under the eyes | |
JP2002538091A (ja) | スキンケア組成物 | |
JP4731009B2 (ja) | 外用ゲル組成物 | |
JP2980679B2 (ja) | 改善された油コントロール性を有するゲルタイプ組成物 | |
KR100356553B1 (ko) | 친수성 증점 화합물 및 다당 알킬 에테르를 함유한 유제, 상기 유제를 함유한 조성물 및 이의 용도 | |
AU9742301A (en) | Treatment for skin | |
JP3324927B2 (ja) | 乳化組成物 | |
JPH09255559A (ja) | ゲル状乳化組成物 | |
JP2002104925A (ja) | 皮膚外用剤 | |
JP2012214456A (ja) | フィルム状外用剤組成物 | |
KR19980028150A (ko) | 중화제로서 키토산 또는 그의 유도체를 함유하는 화장료 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040406 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040507 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090521 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100521 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100521 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110521 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120521 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130521 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130521 Year of fee payment: 9 |